Skip to main content
Caplight Logo









NEUWAY Pharma

NEUWAY Pharma

Private
BonnHealthcare & Life Scienceshttps://neuway-pharma.com

Last Round

Convertible Debt

Jun 16, 2021

Total Funding Raised

$27.69M

Company Overview

NEUWAY Pharma is a biotechnology company developing therapies for the treatment of central nervous system (CNS) diseases based on its proprietary drug delivery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug deliveryblood-brain barrierBBB transportengineered protein capsulesEnPCCNS drug deliverycentral nervous systemCNSbiotechnologybiotechrare disease therapeuticsintracellular deliverydrug development pipelinetherapeutic payloadbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NEUWAY Pharma Comparables

Compare NEUWAY Pharma with similar companies based on industry and business-model similarity.

NEUWAY Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gate2Brain
84%
Lauren Sciences LLC
84%
Ossianix
79%

NEUWAY Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJun 16, 2021
Series AMar 1, 2018
GrantAug 1, 2015
GrantApr 1, 2014

NEUWAY Pharma Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2021

    Raised $10M in convertible debt.

  • Mar 1, 2018

    $11.3M round led by Wellington Partners

NEUWAY Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NEUWAY Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NEUWAY Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersBonn
Year Founded2014
Last FundingJun 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?